Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
暂无分享,去创建一个
A. Naranjo | J. Gastier-Foster | J. Maris | K. Matthay | H. Shimada | E. Attiyeh | W. London | M. Hogarty | S. Cohn | H. Katzenstein | M. Collins | N. Esiashvili | Julie R. Park | P. Mattei | C. Twist | A. Marachelian | E. Adkins | M. Handler | Sheena C. Tenney | M. Schmidt | Elizabeth Wagner | E. S. Adkins